BioNexus Gene Lab Corp.
BGLC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,598 | -$2,629 | -$356 | $752 |
| Dep. & Amort. | $153 | $108 | $105 | $108 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $115 | $118 | $833 | -$862 |
| Other Non-Cash | -$904 | $642 | -$31 | $12 |
| Operating Cash Flow | -$2,234 | -$1,761 | $552 | $9 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$227 | -$149 | -$54 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$572 | -$321 | -$512 | -$516 |
| Inv. Sales/Matur. | $1,069 | $26 | $0 | $6 |
| Other Inv. Act. | $148 | -$1,412 | $115 | $22 |
| Investing Cash Flow | $418 | -$1,856 | -$450 | -$491 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$34 | -$26 |
| Stock Issued | $0 | $5,750 | $150 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $145 | $525 | -$8 | -$2 |
| Financing Cash Flow | $145 | $6,275 | $108 | -$28 |
| Forex Effect | $40 | $1,152 | -$215 | -$154 |
| Net Chg. in Cash | -$1,631 | $3,810 | -$5 | -$664 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,518 | $2,119 | $2,124 | $2,788 |
| End Cash | $2,887 | $5,929 | $2,119 | $2,124 |
| Free Cash Flow | -$2,461 | -$1,910 | $498 | $6 |